Pharmafile Logo
Pharmafocus logo
Advanced Search

fibrosis

Showing 6 posts of 6 posts found.

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

December 12, 2024
Corporate, Deep Science Ventures, General Inception, fibrosis, venture

12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and …

News
Press release
Eli Lilly front sign

University of Glasgow and Lilly sign £4.6m immunological disease partnership

February 15, 2021
Sales and Marketing Eli Lilly, University of Glasgow, arthritis, fibrosis, lilly, uofg

The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …

News
8643990124_7c11fee008_z

Gilead and Scholar Rock collaborate on fibrosis in deal worth more than $80m

December 20, 2018
Business Services, Research and Development Califonia, Gilead, Scholar Rock, USA, fibrosis

California-based antiviral drugs specialist Gilead Sciences has entered into a strategic partnership with Cambridge, Massachusetts-based biotech Scholar Rock as part …

News

Bristol-Myers Squibb makes big pharma deals

September 1, 2015
Manufacturing and Production BMS, Bristol-Myers Squibb, PRM-151, Promedior, QIMR, fibrosis, idiopathic pulmonary fibrosis, immuno-oncology, myelofibrosis

Bristol-Myers Squibb is flexing its muscles in respiratory disease, by signing a deal to acquire the exclusive right to acquire …

News

MRC, GSK and universities team up on inflammatory diseases

July 15, 2015
Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …

News
BMS image

BMS launches new fibrosis research collaboration

January 6, 2015
Research and Development, Sales and Marketing BMS, BMS-986020, calibr, california, fibrosis, fibrotic

Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025